Intraoperative blood transfusion contributes to decreased long-term survival of patients with esophageal cancer

World Journal of Surgery

Volumn 36, Issue 4, 2012, Pages 844-850

  Komatsu, Yoshihiro ^a   Orita, Hajime ^a   Sakurada, Mutsumi ^a   Maekawa, Hiroshi ^a   Hoppo, Toshitaka ^b   Sato, Koichi ^a  

^a JUNTENDO UNIVERSITY SHIZUOKA HOSPITAL   (Japan)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; FEMALE; HUMAN; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TIME;

AGED; AGED, 80 AND OVER; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84863717246     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-012-1433-3     Document Type: Article

References (34)

1. Jemal A, Siegel R, Ward E et al (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225-249
2. Cohen DJ, Ajani J (2011) An expert opinion on esophageal cancer therapy. Expert Opin Pharmacother 12:225-239
3. Demeester SR (2009) Epidemiology and biology of esophageal cancer. Gastrointest Cancer Res 3(Suppl):S2-S5
4. Osugi H, Takemura M, Takada N et al (2002) Prognostic factors after oesophagectomy and extended lymphadenectomy for squamous oesophageal cancer. Br J Surg 89:909-913
5. Kitagawa Y (2008) Therapeutic strategies for advanced respectable esophageal cancer. Nippon Geka Gakkai Zasshi 109:333-337
6. Higuchi K, Koizumi W, Tanabe S et al (2009) Current management of esophageal squamous-cell carcinoma in Japan and other countries. Gastrointest Cancer Res 3:153-161
7. Tsurumaru M, Kajiyama Y, Udagawa H et al (2001) Outcomes of extended lymph node dissection for squamous cell carcinoma of the thoracic esophagus. Ann Thorac Cardiovasc Surg 7:325-329
8. Tachibana M, Kinugasa S, Dhar DK et al (1999) Prognostic factors after extended esophagectomy for squamous cell carcinoma of the thoracic esophagus. J Surg Oncol 72:88-93
9. Tachibana M, Kinugasa S, Dhar DK et al (1999) Prognostic factors in T1 and T2 squamous cell carcinoma of the thoracic esophagus. Arch Surg 134:50-54
10. Hu Y, Zheng B, Rong TH et al (2010) Prognostic analysis of the patients with stage-III esophageal squamous cell carcinoma after radical esophagectomy. Chin J Cancer 29:178-183
11. Katz SC, Shia J, Liau KH et al (2009) Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg 249:617-623
12. Nagai S, Fujii T, Kodera Y et al (2011) Impact of operative blood loss on survival in invasive ductal adenocarcinoma of the pancreas. Pancreas 40:3-9
13. Oefelein MG, Colangelo LA, Rademaker AW et al (1995) Intraoperative blood loss and prognosis in prostate cancer patients undergoing radical retropubic prostatectomy. J Urol 154(Pt 1):442-447
14. Tartter PI (1992) The association of perioperative blood transfusion with colorectal cancer recurrence. Ann Surg 216:633-638
15. Ojima T, Iwahashi M, Nakamori M et al (2009) Association of allogeneic blood transfusions and long-term survival of patients with gastric cancer after curative gastrectomy. J Gastrointest Surg 13:1821-1830
16. Takemura M, Osugi H, Higashino M et al (2005) Effect of substituting allogenic blood transfusion with autologous blood transfusion on outcomes after radical oesophagectomy for cancer. Ann Thorac Cardiovasc Surg 11:293-300
17. Tachibana M, Tabara H, Kotoh T et al (1999) Prognostic significance of perioperative blood transfusions in resectable thoracic esophageal cancer. Am J Gastroenterol 94:757-765
18. Peyre CG, Hagen JA, DeMeester SR et al (2008) Predicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodes. Ann Surg 248:979-985
19. Mariette C, Piessen G, Briez N et al (2008) The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Ann Surg 247:365-371
20. Altorki N, Kent M, Ferrara C et al (2002) Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 236:177-183
21. Lerut T, Nafteux P, Moons J et al (2004) Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome - a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg 240:962-972; discussion 972-964
22. Nishihira T, Hirayama K, Mori S (1998) A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus. Am J Surg 175:47-51
23. Kobayashi S, Asano T, Ochiai T (2001) A proposal of no-touch isolation technique in pancreatoduodenectomy for periampullary carcinomas. Hepatogastroenterology 48:372-374
24. Dhar DK, Kubota H, Tachibana M et al (2000) Long-term survival of transmural advanced gastric carcinoma following curative resection: multivariate analysis of prognostic factors. World J Surg 24:588-593; discussion 593-584. doi:10.1007/s0026899 10099
25. Kamei T, Kitayama J, Yamashita H et al (2009) Intraoperative blood loss is a critical risk factor for peritoneal recurrence after curative resection of advanced gastric cancer. World J Surg 33:1240-1246. doi:10.1007/s00268-009-9979- 4
26. Bruns CJ, Schafer H, Wolfgarten B et al (1996) Einfluss des intraoperativen Blutverlustes auf die Funktion der naturlichen Killerzellen bei Tumoren des oberen Gastrointestinaltraktes [Effect of intraoperative blood loss on the function of natural killer cells in tumors of the upper gastrointestinal tract]. Langenbecks Arch Chir Suppl Kongressbd 113:146-149
27. Roumen RM, Hendriks T, van der Ven-Jongekrijg J et al (1993) Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma: relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg 218:769-776
28. Cue JI, Peyton JC, Malangoni MA (1992) Does blood-transfusion or hemorrhagic-shock induce immunosuppression. J Trauma 32: 613-617
29. Younes RN, Rogatko A, Brennan MF (1991) The influence of intraoperative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastases. Ann Surg 214:107-113
30. Ydy LR, Slhessarenko N, de Aguilar-Nascimento JE (2007) Effect of perioperative allogeneic red blood cell transfusion on the immune-inflammatory response after colorectal cancer resection. World J Surg 31:2044-2051. doi:10.1007/s00268-007-9159-3
31. Dresner SM, Lamb PJ, Shenfine J et al (2000) Prognostic significance of peri-operative blood transfusion following radical resection for oesophageal carcinoma. Eur J Surg Oncol 26:492-497
32. Lieberman MD, Shou J, Sigal RK et al (1990) Transfusioninduced immunosuppression results in diminished host survival in a murine neuroblastoma model. J Surg Res 48:498-503
33. Kaplan J, Sarnaik S, Gitlin J et al (1984) Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions. Blood 64:308-310
34. Osugi H, Takemura M, Higashino M et al (2003) Causes of death and pattern of recurrence after esophagectomy and extended lymphadenectomy for squamous cell carcinoma of the thoracic esophagus. Oncol Rep 10:81-87